Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTQFZWR)

• DTT Name: Hepatitis C virus Core protein messenger RNA (HCV Core mRNA) DTT Info
• Gene Name: HCV Core mRNA

Molecule-Related Drug & Molecule List

8 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
US10087167, Compound 3002	DMM6WAB	N. A.	N. A.	Patented	[1]
US10087167, Compound 3003	DMITOY6	N. A.	N. A.	Patented	[1]
US10087167, Compound 4001	DMAP1DN	N. A.	N. A.	Patented	[1]
US10150740, Example 1	DME2AZG	N. A.	N. A.	Patented	[2]
US10150740, Example 4	DMKM93Q	N. A.	N. A.	Patented	[2]
US10150740, Example 9	DM1VPLU	N. A.	N. A.	Patented	[2]
US8877733, 27	DMDN8P1	N. A.	N. A.	Patented	[3]
US8877733, 28	DMLY3RE	N. A.	N. A.	Patented	[3]

1 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ISIS 11155	DMB31GR	Discovery agent	N.A.	Investigative	[4]

References

• [1] Benzofurans substituted with secondary benzamide as HCV inhibitors. US10087167.
• [2] 6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection. US10150740.
• [3] 1-substituted pyrimidine N-nucleoside analogs for antiviral treatment. US8877733.
• [4] US patent application no. 6,391,542, Compositions and methods for treatment of Hepatitis C virus-associated diseases.